Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 May 8.
Published in final edited form as: Fertil Steril. 2010 Nov 10;95(4):1385–9.e1. doi: 10.1016/j.fertnstert.2010.10.030

The nucleolar channel system reliably marks the midluteal endometrium regardless of fertility status: a fresh look at an old organelle

Eli A Rybak a,b, Michael Szmyga a, Gregory Zapantis b,c, Mary Rausch d, Victor E Beshay e, Alex J Polotsky b, Christos Coutifaris d, Bruce R Carr e, Nanette Santoro b,f, U Thomas Meier a
PMCID: PMC3347775  NIHMSID: NIHMS328822  PMID: 21067716

Abstract

Objective

To determine if nucleolar channel systems (NCSs) in the midluteal endometrium are associated with overall fertility status and/or with unexplained infertility.

Design

Retrospective and prospective clinical studies.

Setting

Repository of stored specimens from prior multicenter study and private infertility center, respectively.

Patients

Retrospective study: 97 women (49 fertile couples, 48 infertile couples) who had been randomized for endometrial biopsy during the midluteal or late luteal phase. Prospective study: 78 women with a variety of infertility diagnoses.

Intervention

Endometrial biopsies were obtained and assessed for the presence of NCSs by indirect immunofluorescence.

Main Outcome Measures

NCS presence was graded semi-quantitatively and dichotomized as normal versus low or absent.

Results

Normal NCS presence was significantly associated with the midluteal phase compared to the late luteal phase (80% versus 29%). However, there was no association between NCS presence and fertility status or between NCS presence and unexplained infertility.

Conclusions

Midluteal phase endometrium consistently forms NCSs regardless of fertility status, including unexplained infertility. This indicates a possible role for the NCS in initiating the window of endometrial receptivity. However, the consistent presence of NCSs across several different types of infertility challenges the likelihood that inadequate secretory transformation is a cause of infertility.

Keywords: Nucleolar channel system, secretory transformation, receptivity, endometrium, unexplained infertility, immunofluorescence

INTRODUCTION

Fifty years ago, an enigmatic organelle associated with secretory transformation of the endometrium was discovered on the ultrastructural level, and dubbed the nucleolar channel system (NCS) (1). Precise functional and structural characterization of the NCS remains elusive; what is known a half-century later is that the NCS develops transiently in the nuclei of secretory endometrial epithelial cells (EECs) as a membranous organelle of uniform size, ~1 μm diameter, that is associated with the nuclear envelope and often with a nucleolus, and is comprised of several layers of intertwining membrane tubules embedded in an electron dense granular matrix that, together, surround an amorphous core (2-5). In prior work (5), we established a robust method to stain and identify NCSs on a light microscopic level via an immunofluorescence approach using an antibody directed against a subset of nuclear pore complex proteins, a major component of the NCS. Using this method, we determined that NCSs are present in roughly half of all EEC-nuclei during a period preceding and overlapping with the implantation window: Cycle days (CD) 19-24 of an idealized 28-day cycle (5). This 50% prevalence is ten-fold more abundant than previously reported from ultrastructural identification. Additionally, we demonstrated that the NCS is specific to healthy, human EECs during the secretory phase: It is not present in proliferative endometrium, endometrial stromal cell nuclei, other hormonally sensitive human tissue such as breast tissue, endometrial carcinoma specimens, or in baboon endometrium (5).

In addition to its temporal association with the implantation window, the NCS has received significant attention as an important part of normal uterine biology possibly related to endometrial receptivity. Several observations, derived from multiple ultrastructural studies, support such a role: First, the NCS is induced by progesterone in vivo, whether it is made endogenously or administered exogenously (6-9). Second, the NCS is not found in pregnancy, but remains specific to the midluteal period (2,10). Third, oral contraceptive use and intrauterine device insertion have been shown to interfere with NCS formation and to prematurely induce its formation during the proliferative phase (11-14). Fourth, administration of high-dose ethinyl estradiol for emergency contraception results in the specific loss of NCSs, whereas glycogen deposits and giant mitochondria, other ultrastructural hallmarks of secretory EECs, develop normally (15). Fifth, controlled ovarian hyperstimulation increased the number and size of NCSs in the endometrial epithelium of 15 women undergoing IVF compared to those of 15 control women (16). Finally, in several women with unexplained primary infertility lasting from 4.5 to 8 years, the absence of NCSs was the sole abnormal parameter noted in their secretory endometrium (7,17). In other cases of unexplained infertility, the development of the NCS was delayed (18).

Endometrial receptivity during the midluteal implantation window in the human menstrual cycle requires secretory transformation of the estrogen-primed proliferative endometrium. (19,20). Characteristic changes heralding secretory transformation result from progressive progesterone exposure, and include the appearance of basal vacuolation – the first histologic evidence of ovulation (21), the “secretory triad” of postovulatory ultrastructural findings in the glandular epithelium, namely, glycogen accumulation, the nucleolar channel system, and giant mitochondria (22); pinopode expression on the luminal epithelium (23), the decline of epithelial estrogen and progesterone receptors, although not the stromal progesterone receptors – which are maintained (19), and various genetic and immunohistochemical biomarkers that are specific to a secretory phase endometrium (24-26). Nevertheless, the question remains regarding the extent to which infertility can be attributed to inadequate secretory transformation hindering endometrial receptivity. The multicenter randomized controlled trial by the Reproductive Medicine Network demonstrated that women of infertile couples were no likelier to have an out-of-phase endometrial biopsy – suggestive of inadequate secretory transformation – than were women of fertile couples (27). This finding invalidated the use of classic histologic dating of timed endometrial biopsies for routine fertility investigation and the diagnosis of a luteal phase defect, but as the authors of the study themselves noted, it did not preclude the possibility that a defect in secretory transformation might cause infertility in at least some instances. And, indeed, the use of Noyes’ criteria for classic histologic dating of the secretory endometrium for diagnostic purposes has long been controversial due to the substantial intersubject, intrasubject, and interobserver variability that limit its precision, as well as concerns about the variability introduced by the endometrial sampling procedure (28-31). The availability, however, of a readily detectable, abundant marker of secretory transformation, the NCS (5), enables a fresh look at the relationship between inadequate secretory transformation and infertility.

Based on the ultrastructural data showing the NCS to be directly relevant to endometrial receptivity (6-18, 32), we hypothesized that NCS presence would vary by fertility status and by specific infertility diagnosis. Therefore, our objectives were as follows: First, to confirm the association of the NCS with the midluteal phase; second, to determine if NCS presence is associated with overall fertility status; and third, to determine if NCS presence is specifically associated with unexplained infertility.

MATERIALS AND METHODS

Participants

Endometrial biopsies were obtained from two sources: First, from the repository of the National Institute of Child Health and Human Development–sponsored Reproductive Medicine Network (RMN) at 2 of the 12 academic centers that participated in the original study (27) and that had a research consent form allowing for future research on the specimens, Site A (University of Pennsylvania) and Site B (University of Texas-Southwestern Medical Center). After the study was approved by the respective institutional review boards (IRBs) at the Albert Einstein College of Medicine and the two RMN Sites, 107 endometrial biopsies were received, 97 of which contained sufficient glands for NCS scoring. Among the Site A specimens, stratification by luteal phase timing and fertility status, respectively, revealed no statistically significant differences in age, racial composition, fertility status, or biopsy timing (see Supplemental Material). Second, 78 endometrial biopsies were obtained, during a natural cycle and without hormonal medication, from patients with various infertility diagnoses from Site C (East Coast Fertility, a private fertility center in Long Island, NY), with IRB approval. Site A and B endometrial biopsies were processed as previously described (27) and preserved as frozen or paraffin sections. Site C specimens were obtained using a Pipelle suction catheter, formalin fixed, and paraffin embedded, as we described previously (5). For background and cycle information see Supplemental Material.

NCS Imaging and Scoring

Immunostaining was performed essentially as described (5) (see Supplemental Material). Epifluorescent detection and scoring of NCS prevalence was performed on an Axioskop II light microscope (Zeiss, Oberkochen, Germany) using a 63X / 1.4 NA planapo objective. NCS prevalence was graded semi-quantitatively as “normal”, “low”, and “absent” (Figure 1) according to criteria established previously with a training set of biopsies, in which the absolute number of NCSs was determined (5). As observed previously, NCSs appeared and disappeared rapidly within one day, i.e., they were either abundant or they were low or absent (5,32,33). Therefore, the data of the “low” and “absent” categories were combined for binarization. Designation as “normal” required the presence of NCSs in >10% of epithelial cell nuclei in at least two distinct regions of the specimen. We previously determined the 10% cutoff using absolute numbers of NCSs (5). The purpose of this study was to establish NCS presence versus absence. In order to quantify NCSs, stereology could be applied (34,35), although that would be challenging for such a large sample set. Nevertheless, only a few samples approached the 10% cutoff, and most were far above or below. Specimens with fewer NCSs in an entire section with an average of 50 – 100 glands were graded as “low”. All sample preparation, immunodetection, and scoring was performed by at least two observers who were blinded to the clinical information associated with each biopsy specimen. Among the specimens (n=175) analyzed, 10.9% received discrepant scores and were reevaluated by a third referee, also blinded, for final grading. This interobserver difference can be explained by slight variations in procedure and identification of NCSs.

Figure 1.

Figure 1

Representative images from Site A paraffin tissue illustrating the divergent appearance of “normal” (A) versus “low” (B) versus “absent” (C) NCS appearance as detected by indirect immunofluorescence with mAb414. Note the equal labeling of the nuclear pore complexes outlining the epithelial cell nuclei of all panels and the NCSs within nuclei in panel (A) and (B), some of which are indicated (arrows). Bar = 20μm.

RESULTS

Consistent with our prior results (5), NCS presence was far greater in the midluteal (80%, n=30) compared with the late luteal phase (29%, n=31; P<.001, Table 1). When these groups were stratified by fertility status, the association persisted (Table 1). Endometrial specimens from fertile compared with infertile couples demonstrated similar NCS presence (55.1% versus 52.1%, respectively; P=.77, Table 2). Stratification by timing of the biopsy reinforced the lack of association between NCS presence and fertility status (Table 2): Among midluteal specimens, an identical proportion (80%) of fertile compared with infertile couples demonstrated normal NCS presence, and among late luteal specimens, the difference in normal NCS presence between fertile couples (36.8%) and infertile couples (16.7%) was not statistically significant (P=.23).

Table 1.

Percentage of normal presence of nucleolar channel systems among Site A specimens by luteal phase timing.

Midluteal
(n=30)
Late Luteal
(n=31)
P value
All patients (n=61) 80% (24/30) 29% (9/31) <.001a
Fertile patients only (n=39) 80% (16/20) 36.8% (7/19) .006a
Infertile patients only (n=22) 80% (8/10) 16.7% (2/12) .008b

Data is categorical and is presented as percentages (proportion). Comparisons among groups with a smaller sample size were calculated by Fisher’s exact test, rather than Chi square.

a

Chi square.

b

Fisher’s exact test.

Table 2.

Percentage of normal presence of nucleolar channel systems among all luteal phase specimens by fertility status.

Fertile
Patients
Infertile
Patients
P value
Site A specimens – Midluteal only (n=30) 80% (16/20) 80% (8/10) 1a
Site A specimens – Late Luteal only (n=31) 36.8% (7/19) 16.7% (2/12) .23b
Site B specimens (approximately half
midluteal and half late luteal; n=36)
40% (4/10) 57.7% (15/26) .46b

Site A and B specimens combined (n=97) 55.1% (27/49) 52.1% (25/48) .77b

Site C specimens at Cycle Day 19-22 (n=78) --- 97.4% (76/78) ---

Data is categorical and is presented as percentages (proportion). Comparisons among groups with a smaller sample size were calculated by Fisher’s exact test, rather than Chisquare.

a

Fisher’s exact test.

b

Chi square.

To further test these findings, we analyzed midluteal biopsies from a cohort of exclusively infertile patients with various diagnoses of infertility (n=78, Site C). Almost all of these samples (97.4%) exhibited normal NCS presence (Table 2). These 78 biopsies were then stratified by cause of infertility into two groups (Table 3): unexplained infertility (n=21) versus infertility attributed to a known diagnosis (not unexplained, n=57). The two groups did not differ significantly along any measured demographic or clinical parameter. Importantly, they did not differ significantly in the proportion of specimens demonstrating normal NCS presence (95.2% versus 98.2%, respectively).

Table 3.

Percentage of normal presence of nucleolar channel systems (NCSs) and clinical characteristics of Site C specimens by cause of infertility.

Specific Infertility
Diagnosis
(n=57)
Unexplained
Infertility
(n=21)
P value
Normal NCS presence 98.2 % (56/57) 95.2 % (20/21) .47a

Age, years 35.9 ± 5.4 35.4 ± 3.5 .7b
BMI, m/kg2 23.5 (21.9-27.3) 25.8 (20.8-30.7) .3c
E2/P4 ratio on biopsy day 11.4 (7.8-15.9) 9.5 (5.7-12.9) .35c
P4 on biopsy day, ng/mL 10.8 ± 3.7 11.4 ± 3.2 .56b
E2 on biopsy day, pg/mL 121(87.2-152) 98.8 (80.1-151) .53c
Histologic dating, cycle day 19 (17-21) 18 (16.5-19.5) .4c
LH surge dating, cycle day 20 (20-21) 20 (20-21) .26c

Note: Continuous data are presented as mean ± standard deviation (if normally distributed) or as median (interquartile range) if skewed; categorical data are presented as percentages (proportion).

a

Fisher’s exact test.

b

Student’s t-test.

c

Mann-Whitney.

DISCUSSION

The specificity of the NCS for the midluteal phase suggests that this mysterious organelle is not merely a progesterone sensitive structure that appears and endures – like pinopodes (23) – once requisite levels of progesterone are achieved but, rather, may function to promote endometrial receptivity during the implantation window. Importantly, our findings confirm the NCS as a marker of secretory transformation that reliably and ubiquitously delineates midluteal endometrium, but not as a marker for fertility status.

Counter to our hypothesis, which was based on significant ultrastructural evidence (see Introduction; 6-13, 15-17), NCS appearance failed to discriminate by both overall fertility status and by unexplained versus not-unexplained infertility. Considering this discrepancy, we note that some etiologies of infertility (e.g. tubal factor, diminished ovarian reserve) in our study are not related to NCS appearance. Moreover, the grouping by the RMN study design (27) of couples with male factor infertility within the infertile group, despite having a presumably normal NCS appearance pattern, might inaccurately inflate the rate of normal NCS appearance among infertile couples. However, these points fail to explain the similar prevalence of NCSs in the fertile versus infertile groups given that unexplained infertility is not attributable to diminished NCS appearance and, importantly, there is no evidence of a lack of NCS appearance associated with any of the various causes of infertility described by Site C. Therefore, the previous under-detection of the actual prevalence of NCSs may result from the fact that ultrastructural analysis affords a more detailed albeit focused approach, in contrast to our light microscopic approach (5), which enables a survey of larger sections of the endometrial biopsies.

Unsurprisingly, when we compared unexplained infertile couples with those having known infertility diagnoses, there were no differences in the midluteal (biopsy day) levels of progesterone, estradiol, or the ratio between them. Should an as-of-yet uncharacterized endometrial finding elucidate the pathophysiology of some cases of unexplained infertility (36,37), it will likely be insensitive to, at least, moderate variations in circulating progesterone and estradiol levels during the midluteal phase. Indeed, a recent study reports no correlation between circulating progesterone levels and specific histologic, immunohistochemical, and quantitative RT-PCR findings in the secretory endometrium (38). Specifically, the characteristic features of secretory transformation appear despite the experimental induction (through subphysiological progesterone levels) of a luteal phase defect (38). Taken together, these findings imply that only very small quantities of progesterone are necessary for the induction of secretory transformation, including the expression of NCSs.

The original RMN study invalidated the use of a timed secretory-phase endometrial biopsy for the diagnosis of a luteal phase defect (27). However, due to potential inaccuracies involved in the process of obtaining and interpreting endometrial biopsies, the study does not definitively rule out the possibility that inadequate endometrial secretory transformation underlies at least some types of infertility. The reliable and ubiquitous specificity of the NCS for midluteal endometrium confirms ultrastructural evidence that NCS presence is a strong biomarker for secretory transformation. Inversely, diminished or absent NCS presence in the midluteal endometrium suggests inadequate secretory transformation. Our findings of equivalent rates of inadequate secretory transformation – as reflected by diminished or absent NCS presence – between fertile versus infertile women and between unexplained versus not-unexplained infertile women, respectively, further suggest that inadequate secretory transformation does not contribute to infertility. This lack of association between inadequate secretory transformation and infertility poses a direct challenge to the existence of an endometrial cause of infertility due to lack of appropriate receptivity. At the very least, our data and the aforecited study demonstrating the minimal – if any – threshold of circulating progesterone required for secretory transformation (38), highlight the need to better define what criteria constitute successful secretory transformation prior to assuming that insufficiency in that process might contribute to infertility.

Unexpectedly, the site A and B midluteal samples exhibited only an 80% NCS prevalence compared to the near 100% of the site C samples and to those we determined previously (5). The most likely explanation for this discrepancy is a slight degradation of the site A and B samples, which were procured in 1999-2002. Extended storage and transport may have contributed to a loss of NCSs and/or their detection. In contrast, all site C samples were analyzed for NCS presence within a few days to weeks of collection.

In summary, as a secretory-phase structure first identified a half-century ago, the notion that the NCS might play a role in endometrial receptivity has been proffered for many years. The use of a highly sensitive immunofluorescence approach has concretized the significant and specific association between the NCS and the midluteal phase, thereby fortifying the NCS’s credentials as a marker of secretory transformation, even as its presence does not discriminate by fertility status or unexplained infertility. In fact, the omnipresence of the NCS in the midluteal endometrium may mark it as a prerequisite for human fertility. Further structural and functional dissection of the NCS may provide a fresh approach in the ongoing quest to unravel the complexities of endometrial receptivity.

Supplementary Material

1

CAPSULE.

Nucleolar channel systems appear reliably in midluteal endometrium independent of fertility status, including unexplained infertility, thus further questioning the relevance of inadequate secretory transformation as a cause of infertility.

Acknowledgments

We are grateful to Elisa Guffanti and Gayatri Sarkar for help with NCS grading of Site C samples. We thank the Reproductive Medicine Network for access to its repository of timed luteal phase endometrial biopsies (at the University of Pennsylvania and the University of Texas - Southwestern Medical Center). All imaging was performed at the Analytical Imaging Facility and all slides were prepared by the Histotechnology and Comparative Pathology Facility of the Albert Einstein College of Medicine.

Financial Support: March of Dimes Birth Defects Foundation (#1-FY09-363 to UTM); CMBG Training Program (T32 GM007491 to MS); Ferring Pharmaceuticals, Parsippany, NJ (to GZ)

Footnotes

Presented at the 57th annual meeting of the Society for Gynecologic Investigation, Orlando, FL, March 25, 2010.

Supplemental Material Online For additional Material and Methods, including outcome measures and statistical analyses, see Supplemental Material online.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Conflict of Interest (for all authors): NONE

REFERENCES

  • 1.Dubrauszky V, Pohlmann G. Strukturveränderungen am Nukleolus von Korpusendometriumzellen während der Sekretionsphase. Naturwissenschaften. 1960;47:523–4. [Google Scholar]
  • 2.Clyman MJ. A new structure observed in the nucleolus of the human endometrial epithelial cell. Am J Obstet Gynecol. 1963;86:430–432. doi: 10.1016/0002-9378(63)90166-2. [DOI] [PubMed] [Google Scholar]
  • 3.Terzakis JA. The nucleolar channel system of the human endometrium. J. Cell Biol. 1965;27:293–304. doi: 10.1083/jcb.27.2.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Spornitz UM. The functional morphology of the human endometrium and decidua. Adv Anat Embryol Cell Biol. 1992;124:1–99. doi: 10.1007/978-3-642-58099-4. [DOI] [PubMed] [Google Scholar]
  • 5.Guffanti E, Kittur N, Brodt ZN, Polotsky AJ, Kuokkanen SM, Heller DS, et al. Nuclear pore complex proteins mark the implantation window in human endometrium. J Cell Sci. 2008;121:2037–45. doi: 10.1242/jcs.030437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kohorn EI, Rice SI, Gordon M. In vitro production of nucleolar channel system by progesterone in human endometrium. Nature. 1970;228:671–2. doi: 10.1038/228671a0. [DOI] [PubMed] [Google Scholar]
  • 7.Kohorn EI, Rice SI, Hemperly S, Gordon M. The relation of the structure of progestational steroids to nucleolar differentiation in human endometrium. J Clin Endocrinol Metab. 1972;34:257–64. doi: 10.1210/jcem-34-2-257. [DOI] [PubMed] [Google Scholar]
  • 8.Pryse-Davies J, Ryder TA, MacKenzie ML. In vivo production of the nucleolar channel system in post menopausal endometrium. Cell Tissue Res. 1979;203:493–8. doi: 10.1007/BF00233277. [DOI] [PubMed] [Google Scholar]
  • 9.Roberts DK, Horbelt DV, Powell LC., Jr. The ultrastructural response of human endometrium to medroxyprogesterone acetate. Am J Obstet Gynecol. 1975;123:811–8. doi: 10.1016/0002-9378(75)90854-6. [DOI] [PubMed] [Google Scholar]
  • 10.Demir R, Kayisli UA, Celik-Ozenci C, Korgun ET, Demir-Weusten AY, Arici A. Structural differentiation of human uterine luminal and glandular epithelium during early pregnancy: an ultrastructural and immunohistochemical study. Placenta. 2002;23:672–84. doi: 10.1053/plac.2002.0841. [DOI] [PubMed] [Google Scholar]
  • 11.Azadian-Boulanger GJ, Secchi J, Laraque F, Raynaud JP, Sakiz E. Action of midcycle contraceptive (R 2323) on the human endometrium. Am J Obstet Gynecol. 1976;125:1049–56. doi: 10.1016/0002-9378(76)90807-3. [DOI] [PubMed] [Google Scholar]
  • 12.Feria-Velasco A, Aznar-Ramos R, Gonzalez-Angulo A. Ultrastructural changes found in the endometrium of women using megestrol acetate for contraception. Contraception. 1972;5:187–201. doi: 10.1016/0010-7824(72)90045-5. [DOI] [PubMed] [Google Scholar]
  • 13.Wynn RM. Intrauterine devices: effects on ultrastructure of human endometrium. Science. 1967;156:1508–10. doi: 10.1126/science.156.3781.1508. [DOI] [PubMed] [Google Scholar]
  • 14.Dockery P, Ismail RMJ, Li TC, Warren MA, Cooke ID. The effect of a single dose of mifepristone (RU486) on the fine structure of the human endometrium during the early luteal phase. Hum Reprod. 1997;12:1778–84. doi: 10.1093/humrep/12.8.1778. [DOI] [PubMed] [Google Scholar]
  • 15.van Santen MR, Haspels AA, Heijnen HF, Rademakers LH. Interfering with implantation by postcoital estrogen administration. II. Endometrium epithelial cell ultrastructure. Contraception. 1988;38:711–24. doi: 10.1016/0010-7824(88)90052-2. [DOI] [PubMed] [Google Scholar]
  • 16.Novotny R, Malinsky J, Oborna I, Dostal J. Nuclear channel system (NCS) in normal endometrium and after hormonal stimulation. Acta Univ Palacki Olomuc Fac Med. 1999;142:41–6. [PubMed] [Google Scholar]
  • 17.Gore BZ, Gordon M. Fine structure of epithelial cell of secretory endometrium in unexplained primary infertility. Fertil Steril. 1974;25:103–7. doi: 10.1016/s0015-0282(16)40208-6. [DOI] [PubMed] [Google Scholar]
  • 18.Dockery P, Pritchard K, Warren MA, Li TC, Cooke ID. Changes in nuclear morphology in the human endometrial glandular epithelium in women with unexplained infertility. Hum Reprod. 1996;11:2251–6. doi: 10.1093/oxfordjournals.humrep.a019085. [DOI] [PubMed] [Google Scholar]
  • 19.Lessey BA, Glasser S. Endometrial receptivity. In: Aplin JD, Fazleabas AT, Glasser SR, Giudice LC, editors. The Endometrium. 2nd ed Informa Healthcare; NewYork: 2008. pp. 305–18. [Google Scholar]
  • 20.Sharkey AM, Smith SK. The endometrium as a cause of implantation failure. Best Pract Res Clin Obstet Gynecol. 2003;17:289–307. doi: 10.1016/s1521-6934(02)00130-x. [DOI] [PubMed] [Google Scholar]
  • 21.Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril. 1950;1:3–25. doi: 10.1016/j.fertnstert.2019.08.079. [DOI] [PubMed] [Google Scholar]
  • 22.Cornille FJ, Lauweryns JM, Brosens IA. Normal human endometrium: an ultrastructural survey. Gynecol Obstet Invest. 1985;20:113–29. doi: 10.1159/000298983. [DOI] [PubMed] [Google Scholar]
  • 23.Quinn C, Ryan E, Claessens EA, Greenblatt E, Hawrylyshyn P, Cruickshank B, et al. The presence of pinopodes in the human endometrium does not delineate the implantation window. Fertil Steril. 2007;87:1015–21. doi: 10.1016/j.fertnstert.2006.08.101. [DOI] [PubMed] [Google Scholar]
  • 24.Mirkin S, Arslan M, Churikov D, Corica A, Diaz JI, Williams S, et al. In search of candidate genes critically expressed in the human endometrium during the window of implantation. Hum Reprod. 2005;20:2104–17. doi: 10.1093/humrep/dei051. [DOI] [PubMed] [Google Scholar]
  • 25.Achache H, Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update. 2006;12:731–46. doi: 10.1093/humupd/dml004. [DOI] [PubMed] [Google Scholar]
  • 26.Aghajanova L, Hamilton AE, Giudice LC. Uterine receptivity to human embryonic implantation: histology, biomarkers, and transcriptomics. Semin Cell Dev Biol. 2008;19:204–11. doi: 10.1016/j.semcdb.2007.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Coutifaris C, Myers ER, Guzick DS, Diamond MP, Carson SA, Legro RS, et al. Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril. 2004;82:1264–72. doi: 10.1016/j.fertnstert.2004.03.069. [DOI] [PubMed] [Google Scholar]
  • 28.Murray MJ, Meyer WR, Zaino RJ, Lessey BA, Novotny DB, Ireland K, et al. A critical analysis of the accuracy, reproducibility, and clinical utility of histologic endometrial dating in fertile women. Fertil Steril. 2004:81-1333–43. doi: 10.1016/j.fertnstert.2003.11.030. [DOI] [PubMed] [Google Scholar]
  • 29.Li TC, Dockery P, Rogers AW, Cooke ID. How precise is histologic dating of endometrium using the standard dating criteria? Fertil Steril. 1989;51:759–63. doi: 10.1016/s0015-0282(16)60662-3. [DOI] [PubMed] [Google Scholar]
  • 30.Gibson M, Badger GJ, Byrn F, Lee KR, Korson R, Trainer TD. Error in histologic dating of secretory endometrium: variance component analysis. Fertil Steril. 1991;56:242–7. doi: 10.1016/s0015-0282(16)54479-3. [DOI] [PubMed] [Google Scholar]
  • 31.Scott RT, Snyder RR, Bagnall JW, Reed KD, Adair CF, Hensley SD. Evaluation of the impact of interobserver variability on endometrial dating and the diagnosis of luteal phase defects. Fertil Steril. 1993;60:652–7. doi: 10.1016/s0015-0282(16)56216-5. [DOI] [PubMed] [Google Scholar]
  • 32.Dockery P, Pritchard K, Taylow A, Li TC, Warren MA, Cooke ID. The fine structure of the human endometrial glandular epithelium in cases of unexplained infertility: a morphometric study. Hum Reprod. 1993;8:667–73. doi: 10.1093/oxfordjournals.humrep.a138117. [DOI] [PubMed] [Google Scholar]
  • 33.Dockery P, Li TC, Rogers AW, Cooke ID, Lenton EA, Warren MA. An examination of the variation in timed endometrial biopsies. Hum Reprod. 1988;3:715–20. doi: 10.1093/oxfordjournals.humrep.a136771. [DOI] [PubMed] [Google Scholar]
  • 34.Sterio DC. The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc. 1984;134:127–36. doi: 10.1111/j.1365-2818.1984.tb02501.x. [DOI] [PubMed] [Google Scholar]
  • 35.West MJ, Slomianka L, Gundersen HJ. Unbiased steriological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec. 1991;231:482–97. doi: 10.1002/ar.1092310411. [DOI] [PubMed] [Google Scholar]
  • 36.Aghajanova L, Altmäe S, Bjuresten K, Hovatta O, Landgren BM, Stavreus-Evers A. Disturbances in the LIF pathway in the endometrium among women with unexplained infertility. Fertil Steril. 2009;91:2602–10. doi: 10.1016/j.fertnstert.2008.04.010. [DOI] [PubMed] [Google Scholar]
  • 37.Altmäe S, Martinez-Conejero JA, Salumets A, Simon C, Horcajadas JA, Stavreus-Evers A. Endometrial gene expression analysis at the time of embryo implantation in women with unexplained infertility. Mol Hum Reprod. 2010;16:178–87. doi: 10.1093/molehr/gap102. [DOI] [PubMed] [Google Scholar]
  • 38.Usadi RS, Groll JM, Lessey BA, Lininger RA, Zaino RJ, Fritz MA, et al. Endometrial development and function in experimentally induced luteal phase deficiency. J Clin Endocrinol Metab. 2008;93:4058–64. doi: 10.1210/jc.2008-0460. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES